CEDRUS’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$324K Sell
2,719
-119
-4% -$14.2K 0.12% 133
2024
Q2
$405K Buy
2,838
+186
+7% +$26.6K 0.2% 92
2024
Q1
$341K Buy
+2,652
New +$341K 0.19% 106